A strategy for risk mitigation of antibodies with fast clearance

References

• Reichert JM. Marketed therapeutic antibodies compendium. MAbs 2012; 4:413 - 5; http://dx.doi.org/10.4161/mabs.19931; PMID: 22531442
   PubMed Web of Science ®Google Scholar
• Wang W, Wang EQ, Balthasar JP. Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 2008; 84:548 - 58; http://dx.doi.org/10.1038/clpt.2008.170; PMID: 18784655
   PubMed Web of Science ®Google Scholar
• Tabrizi MA, Tseng CM, Roskos LK. Elimination mechanisms of therapeutic monoclonal antibodies. Drug Discov Today 2006; 11:81 - 8; http://dx.doi.org/10.1016/S1359-6446(05)03638-X; PMID: 16478695
   PubMed Web of Science ®Google Scholar
• Mager DE. Target-mediated drug disposition and dynamics. Biochem Pharmacol 2006; 72:1 - 10; http://dx.doi.org/10.1016/j.bcp.2005.12.041; PMID: 16469301
   PubMed Web of Science ®Google Scholar
• Mould DR, Green B. Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development. BioDrugs 2010; 24:23 - 39; http://dx.doi.org/10.2165/11530560-000000000-00000; PMID: 20055530
   PubMed Web of Science ®Google Scholar
• Kuo TT, Aveson VG. Neonatal Fc receptor and IgG-based therapeutics. MAbs 2011; 3:422 - 30; http://dx.doi.org/10.4161/mabs.3.5.16983; PMID: 22048693
   PubMed Web of Science ®Google Scholar
• Keizer RJ, Huitema AD, Schellens JH, Beijnen JH. Clinical pharmacokinetics of therapeutic monoclonal antibodies. Clin Pharmacokinet 2010; 49:493 - 507; http://dx.doi.org/10.2165/11531280-000000000-00000; PMID: 20608753
   PubMed Web of Science ®Google Scholar
• Deng R, Iyer S, Theil F-P, Mortensen DL, Fielder PJ, Prabhu S. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?. MAbs 2011; 3:61 - 6; http://dx.doi.org/10.4161/mabs.3.1.13799; PMID: 20962582
   PubMed Web of Science ®Google Scholar
• Dall’Acqua WF, Kiener PA, Wu H. Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J Biol Chem 2006; 281:23514 - 24; http://dx.doi.org/10.1074/jbc.M604292200; PMID: 16793771
   PubMed Web of Science ®Google Scholar
• Hinton PR, Xiong JM, Johlfs MG, Tang MT, Keller S, Tsurushita N. An engineered human IgG1 antibody with longer serum half-life. J Immunol 2006; 176:346 - 56; PMID: 16365427
   PubMed Web of Science ®Google Scholar
• Yeung YA, Leabman MK, Marvin JS, Qiu J, Adams CW, Lien S, et al. Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates. J Immunol 2009; 182:7663 - 71; http://dx.doi.org/10.4049/jimmunol.0804182; PMID: 19494290
   PubMed Web of Science ®Google Scholar
• Zalevsky J, Chamberlain AK, Horton HM, Karki S, Leung IW, Sproule TJ, et al. Enhanced antibody half-life improves in vivo activity. Nat Biotechnol 2010; 28:157 - 9; http://dx.doi.org/10.1038/nbt.1601; PMID: 20081867
   PubMed Web of Science ®Google Scholar
• Wu H, Pfarr DS, Johnson S, Brewah YA, Woods RM, Patel NK, et al. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol 2007; 368:652 - 65; http://dx.doi.org/10.1016/j.jmb.2007.02.024; PMID: 17362988
   PubMed Web of Science ®Google Scholar
• Bumbaca D, Wong A, Drake E, Reyes AE 2nd, Lin BC, Stephan J-P, et al. Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4. MAbs 2011; 3:376 - 86; http://dx.doi.org/10.4161/mabs.3.4.15786; PMID: 21540647
   PubMed Web of Science ®Google Scholar
• Vugmeyster Y, Szklut P, Wensel D, Ross J, Xu X, Awwad M, et al. Complex pharmacokinetics of a humanized antibody against human amyloid beta peptide, anti-abeta Ab2, in nonclinical species. Pharm Res 2011; 28:1696 - 706; http://dx.doi.org/10.1007/s11095-011-0405-x; PMID: 21424161
   PubMed Web of Science ®Google Scholar
• Vugmeyster Y, Guay H, Szklut P, Qian MD, Jin M, Widom A, et al. In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus. MAbs 2010; 2:335 - 46; http://dx.doi.org/10.4161/mabs.2.3.11850; PMID: 20424514
   PubMed Web of Science ®Google Scholar
• Angal S, King DJ, Bodmer MW, Turner A, Lawson AD, Roberts G, et al. A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol Immunol 1993; 30:105 - 8; http://dx.doi.org/10.1016/0161-5890(93)90432-B; PMID: 8417368
   PubMed Web of Science ®Google Scholar
• Lee CV, Liang WC, Dennis MS, Eigenbrot C, Sidhu SS, Fuh G. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol 2004; 340:1073 - 93; http://dx.doi.org/10.1016/j.jmb.2004.05.051; PMID: 15236968
   PubMed Web of Science ®Google Scholar
• Yeung YA, Wu X, Reyes AE 2nd, Vernes JM, Lien S, Lowe J, et al. A therapeutic anti-VEGF antibody with increased potency independent of pharmacokinetic half-life. Cancer Res 2010; 70:3269 - 77; http://dx.doi.org/10.1158/0008-5472.CAN-09-4580; PMID: 20354184
   PubMed Web of Science ®Google Scholar
• Dennis MS, Lowman HB. Phage selection strategies for improved affinity and specificity of proteins and peptides. In: Clackson T, Lowman HB, eds. Phage Display. Oxford, UK: Oxford University Press, 2004:61-94.
   Google Scholar
• Hötzel I, Chiang V, Diao J, Pantua H, Maun HR, Kapadia SB. Efficient production of antibodies against a mammalian integral membrane protein by phage display. Protein Eng Des Sel 2011; 24:679 - 89; http://dx.doi.org/10.1093/protein/gzr039; PMID: 21810920
   PubMed Web of Science ®Google Scholar
• Wang W, Lu P, Fang Y, Hamuro L, Pittman T, Carr B, et al. Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences. Drug Metab Dispos 2011; 39:1469 - 77; http://dx.doi.org/10.1124/dmd.111.039453; PMID: 21610128
   PubMed Web of Science ®Google Scholar
• Igawa T, Tsunoda H, Tachibana T, Maeda A, Mimoto F, Moriyama C, et al. Reduced elimination of IgG antibodies by engineering the variable region. Protein Eng Des Sel 2010; 23:385 - 92; http://dx.doi.org/10.1093/protein/gzq009; PMID: 20159773
   PubMed Web of Science ®Google Scholar
• Winzor DJ. Determination of the net charge (valence) of a protein: a fundamental but elusive parameter. Anal Biochem 2004; 325:1 - 20; http://dx.doi.org/10.1016/j.ab.2003.09.035; PMID: 14715279
   PubMed Web of Science ®Google Scholar
• Yadav S, Laue TM, Kalonia DS, Singh SN, Shire SJ. The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions. Mol Pharm 2012; 9:791 - 802; http://dx.doi.org/10.1021/mp200566k; PMID: 22352470
   PubMed Web of Science ®Google Scholar
• Marheineke K. Lipid Composition of Spodoptera frugiperda (Sf9) and Trichplusia ni (Tn) insect cells used for baculovirus infection. FEBS Lett 1998; 441:4; http://dx.doi.org/10.1016/S0014-5793(98)01523-3
   Web of Science ®Google Scholar
• Wang R, Deng F, Hou D, Zhao Y, Guo L, Wang H, et al. Proteomics of the Autographa californica nucleopolyhedrovirus budded virions. J Virol 2010; 84:7233 - 42; http://dx.doi.org/10.1128/JVI.00040-10; PMID: 20444894
   PubMed Web of Science ®Google Scholar
• Deng R, Loyet KM, Lien S, Iyer S, DeForge LE, Theil FP, et al. Pharmacokinetics of humanized monoclonal anti-tumor necrosis factor-alpha antibody and its neonatal Fc receptor variants in mice and cynomolgus monkeys. Drug Metab Dispos 2010; 38:600 - 5; http://dx.doi.org/10.1124/dmd.109.031310; PMID: 20071453
   PubMed Web of Science ®Google Scholar
• Säfsten P, Klakamp SL, Drake AW, Karlsson R, Myszka DG. Screening antibody-antigen interactions in parallel using Biacore A100. Anal Biochem 2006; 353:181 - 90; http://dx.doi.org/10.1016/j.ab.2006.01.041; PMID: 16510107
   PubMed Web of Science ®Google Scholar
• Stone M. Cross-validatory choice and assessment of statistical predictions. J R Stat Soc, B 1974; 36:111 - 47
   Google Scholar
• Geisser S. The predictive sample reuse method with applications I. Amer Stat Assoc 1975; 70:320 - 8; http://dx.doi.org/10.1080/01621459.1975.10479865
   Web of Science ®Google Scholar